InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| CFA | IL10- and IL35-Secreting MutuDC Lines Act in Cooperation to Inhibit Memory T ... | 2021 | Front. Immunol. | Koga M.M. et al. | DOI: 10.3389/fimmu.2021.607315 |
| Ruxolitinib | Transient prenatal ruxolitinib treatment suppresses astrogenesis during devel... | 2021 | Sci Rep. | Lee H.C. et al. | DOI: 10.1038/s41598-021-83222-z |
| Plasmocin® - Mycoplasma Elimination Reagent | AraC-FdUMP[10] (CF10) is a next generation fluoropyrimidine with potent antit... | 2021 | Mol Cancer Res. | Haber A.O. et al. | DOI: 10.1158/1541-7786.MCR-20-0985 |
| Plasmocin® - Mycoplasma Elimination Reagent | PLA2R1 promotes DNA damage and inhibits spontaneous tumor formation during ag... | 2021 | Cell Death Dis. | Huna A. et al. | DOI: 10.1038/s41419-021-03468-3 |
| LPS-EB (LPS from E. coli O111:B4) | IL-22 promotes the formation of a MUC17 glycocalyx barrier in the postnatal s... | 2021 | Cell Rep. | Layunta E. et al. | DOI: 10.1016/j.celrep.2021.108757 |
| IL-2 & IL-15 Reporter HEK 293 Cells | Structure-Activity Relationship Analysis of Benzotriazine Analogues as HIV-1 ... | 2020 | Antimicrob Agents Chemother. | Sorensen E.S. et al. | DOI: 10.1128/AAC.00888-20 |
| IL-2 & IL-15 Reporter HEK 293 Cells | Potent immunomodulatory effects of an anti-CEA-IL-2 immunocytokine on tumor t... | 2020 | Oncoimmunology | Kujawski M. et al. | DOI: 10.1080/2162402X.2020.1724052 |
| LPS-EK (LPS from E. coli K12) | Identification of anti‐inflammatory vesicle‐like nanoparticles in honey. | 2021 | J. Extracell. Vesicles | Chen X. et al. | DOI: 10.1002/jev2.12069 |
| Plasmocin® - Mycoplasma Elimination Reagent | NRF2 Activation Confers Resistance to eIF4A Inhibitors in Cancer Therapy | 2021 | Cancers (Basel). | Sanghvi V.R. et al. | DOI: 10.3390/cancers13040639 |
| pFUSE-hIgG1-Fc | Targeting galectin-3 with a high-affinity antibody for inhibition of high-gra... | 2021 | Sci Rep. | Stasenko M. et al. | DOI: 10.1038/s41598-021-82686-3 |
| Quil-A® adjuvant | Analysis of Immune Gene Expression in Seabass (Lates calcarifer) Immunized wi... | 2021 | Indian J. Anim. Res. | Sivasankar P et al | DOI: 10.18805/IJAR.B-3813 |
| Zeocin® | Identification, heterologous production and bioactivity of lentinulin A and d... | 2021 | Sci Rep. | Matabaro E. et al. | DOI: 10.1038/s41598-021-83106-2 |
| Primocin® | Chromosome-scale genome assembly of the sea louse Caligus rogercresseyi by SM... | 2021 | Sci Data. | Gallardo-Escárate C. et al. | DOI: 10.1038/s41597-021-00842-w |
| LPS-EK (LPS from E. coli K12) | Hypercapnia selectively modulates LPS-induced changes in innate immune and DN... | 2021 | Interface Focus | Casalino-Matsuda S.M. et al. | DOI: 10.1098/rsfs.2020.0039 |
| TLR4-based adjuvant - MPLA-SM VacciGrade™ | The Synergistic Effects of Sulfated Lactosyl Archaeol Archaeosomes When Combi... | 2021 | Pharmaceutics. | Jia Y. et al. | DOI: 10.3390/pharmaceutics13020205 |
| Poly(I:C) (HMW) VacciGrade™ | The Synergistic Effects of Sulfated Lactosyl Archaeol Archaeosomes When Combi... | 2021 | Pharmaceutics. | Jia Y. et al. | DOI: 10.3390/pharmaceutics13020205 |
| Pam3CSK4 VacciGrade™ | The Synergistic Effects of Sulfated Lactosyl Archaeol Archaeosomes When Combi... | 2021 | Pharmaceutics. | Jia Y. et al. | DOI: 10.3390/pharmaceutics13020205 |
| R848 VacciGrade™ | The Synergistic Effects of Sulfated Lactosyl Archaeol Archaeosomes When Combi... | 2021 | Pharmaceutics. | Jia Y. et al. | DOI: 10.3390/pharmaceutics13020205 |
| ODN 2088 | Depletion of Toll-Like Receptor-9 Attenuates Renal Tubulointerstitial Fibrosi... | 2021 | Front. Cell Dev. Biol. | Zheng H. et al. | DOI: 10.3389/fcell.2021.641527 |
| ODN 2088 control | Depletion of Toll-Like Receptor-9 Attenuates Renal Tubulointerstitial Fibrosi... | 2021 | Front. Cell Dev. Biol. | Zheng H. et al. | DOI: 10.3389/fcell.2021.641527 |